{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": {
                "leukocyte_count": "12.57 x 10^9 cells/L",
                "erythrocyte_sedimentation_rate": "68 mm/h",
                "C_reactive_protein_level": "73 mg/L"
            },
            "relevant_findings": "Recurrent fever, oral and genital ulcers, positive pathergy test, anemia, elevated erythrocyte sedimentation rate and C-reactive protein level.",
            "changes_over_time": "After starting anakinra (100 mg/d), there was a dramatic remission in fever and marked improvement in oral and genital ulcers within 7 to 10 days, with culture of blood and sputum negative."
        },
        {
            "date": "May 2006",
            "vital_signs": {
                "temperature": "Not specified",
                "leukocyte_count": "Not specified",
                "erythrocyte_sedimentation_rate": "28% decrease",
                "C_reactive_protein_level": "86% decrease"
            },
            "relevant_findings": "Significant reduction in fever and improvement in oral and genital ulcers with escalated anakinra dosage.",
            "changes_over_time": "When anakinra was reduced to alternate days, oral ulcers and fever reappeared but resolved upon returning to daily dosing."
        }
    ]
}